908 Devices Inc. (MASS)

NASDAQ: MASS · IEX Real-Time Price · USD
5.59
-0.20 (-3.45%)
Apr 17, 2024, 4:00 PM EDT - Market closed
-3.45%
Market Cap 183.97M
Revenue (ttm) 50.23M
Net Income (ttm) -36.40M
Shares Out 32.91M
EPS (ttm) -1.13
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 166,815
Open 5.99
Previous Close 5.79
Day's Range 5.50 - 5.99
52-Week Range 4.85 - 12.51
Beta 0.93
Analysts Buy
Price Target 14.00 (+150.45%)
Earnings Date May 7, 2024

About MASS

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracel... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Dec 18, 2020
Employees 230
Stock Exchange NASDAQ
Ticker Symbol MASS
Full Company Profile

Financial Performance

In 2023, 908 Devices's revenue was $50.23 million, an increase of 7.21% compared to the previous year's $46.85 million. Losses were -$36.40 million, 8.45% more than in 2022.

Financial Statements

Analyst Forecast

According to one analyst, the rating for MASS stock is "Buy" and the 12-month stock price forecast is $14.0.

Price Target
$14.0
(150.45% upside)
Analyst Consensus: Buy
Stock Forecasts

News

908 Devices Trace Chemical Identification Technology Adopted by European Agencies

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announces the latest in international adoption ...

5 weeks ago - Business Wire

908 Devices Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Revenue Outlook

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today reported financial results for the quarte...

6 weeks ago - Business Wire

908 Devices and Cellares Collaborate to Integrate In-line Monitoring of Bioprocess Parameters into the Cell Shuttle, Cellares' Fully Integrated Cell Therapy Manufacturing Platform

BOSTON & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #bioprocessing--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, ...

6 weeks ago - Business Wire

908 Devices to Participate in Upcoming Investor Conferences

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today announced it will participate in the foll...

7 weeks ago - Business Wire

908 Devices to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will report financial results for the four...

2 months ago - Business Wire

908 Devices Announces MX908 Integration Capabilities

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today announced that it has expanded access to ...

5 months ago - Business Wire

908 Devices Reports Third Quarter 2023 Financial Results and Narrows 2023 Revenue Outlook

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today reported financial results for the quarte...

5 months ago - Business Wire

908 Devices and Terumo Blood and Cell Technologies Collaborate to Add On-line Analytics to Quantum Flex Cell Expansion System

BOSTON & LAKEWOOD, Colo.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, and medical technology compan...

5 months ago - Business Wire

908 Devices Awarded $10.4M Order from the United States Air Force for its Handheld MX908 Device

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announces today that it has been awarded a tota...

6 months ago - Business Wire

908 Devices to Report Third Quarter Financial Results on November 7, 2023

BOSTON--(BUSINESS WIRE)--908 Devices Inc., (Nasdaq: MASS) a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will report financial results for the thir...

6 months ago - Business Wire

908 Devices Enters Initial Production Phase of US Department of Defense Aerosol and Vapor Chemical Agent Detector Program

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announces that it has entered the initial produ...

7 months ago - Business Wire

908 Devices Launches MAVERICK for Real-Time In-Line Monitoring of Multiple Bioprocess Parameters

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announces the launch of MAVERICK, an optical in...

7 months ago - Business Wire

908 Devices to Participate in the Gilmartin Group Emerging Growth Company Showcase

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today announced it will participate in the upco...

7 months ago - Business Wire

908 Devices Reports Second Quarter 2023 Financial Results and Updates 2023 Revenue Outlook

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today reported financial results for the quarte...

9 months ago - Business Wire

908 Devices Partners with Tennessee State and Local Agencies in the Fight Against Drug Trafficking Through a New Pilot Program

BOSTON--(BUSINESS WIRE)--908 Devices Inc, (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announces that several Tennessee drug task forc...

9 months ago - Business Wire

908 Devices Launches Remote and Continuous Area Monitoring for Aerosol and Vapor Detection

BOSTON--(BUSINESS WIRE)--908 Devices launches the MX908 Beacon, a unique remote area monitoring system that can detect and identify aerosolized and vapor threats.

9 months ago - Business Wire

908 Devices to Report Second Quarter Financial Results on August 8, 2023

BOSTON--(BUSINESS WIRE)--908 Devices Inc., (Nasdaq: MASS) a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will report financial results for the seco...

9 months ago - Business Wire

908 Devices Features its High-Speed, High-Resolution Separations Technology at the 71st ASMS Conference

BOSTON--(BUSINESS WIRE)--908 Devices Inc (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, is showcasing its ZipChip CE-MS device for rapid...

11 months ago - Business Wire

908 Devices to Participate in the William Blair 43rd Annual Growth Stock Conference

BOSTON--(BUSINESS WIRE)--908 Devices Inc., (Nasdaq: MASS) a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will participate in the upcoming William B...

11 months ago - Business Wire

908 Devices Reports First Quarter 2023 Financial Results and Reiterates 2023 Revenue Outlook

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today reported financial results for the quarte...

1 year ago - Business Wire

908 Devices Launches Data Analysis Visualization Tool for REBEL At-line Cell Culture Media Analyzer

BOSTON--(BUSINESS WIRE)--908 Devices Inc., (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announced the release of a data analysis tool ...

1 year ago - Business Wire

Resilience Demonstrates Lower Cost of Perfusion Bioreactor Process Using 908 Devices' REBEL At-line Analyzer

BOSTON--(BUSINESS WIRE)--908 Devices Inc., (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announced that National Resilience, Inc. (Resi...

1 year ago - Business Wire

908 Devices to Report First Quarter Financial Results on May 9, 2023

BOSTON--(BUSINESS WIRE)--908 Devices Inc., (Nasdaq: MASS) a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will report financial results for the firs...

1 year ago - Business Wire

908 Devices Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Revenue Outlook

BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today reported financial results for the quarte...

1 year ago - Business Wire

908 Devices to Participate in the Cowen 43rd Annual Healthcare Conference

BOSTON--(BUSINESS WIRE)--908 Devices Inc., (Nasdaq: MASS) a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will participate in the upcoming Cowen 43r...

1 year ago - Business Wire